Prime Pharmaceuticals
Mumbai, India· Est.
Indian CDMO Prime Pharmaceuticals delivers high‑quality dosage forms and biosimilars worldwide, backed by extensive regulatory expertise.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian CDMO Prime Pharmaceuticals delivers high‑quality dosage forms and biosimilars worldwide, backed by extensive regulatory expertise.
Technology Platform
GMP‑compliant manufacturing with advanced process analytical technology and continuous manufacturing, supported by a dedicated regulatory affairs team for rapid dossier preparation.
Opportunities
Expanding global demand for affordable biosimilars and complex dosage forms offers significant revenue growth, especially in emerging markets and through digital manufacturing enhancements.
Risk Factors
Regulatory variability across regions and fierce competition from larger CDMOs could pressure margins and limit market share expansion.
Competitive Landscape
Prime competes with global CDMOs like Lonza and Catalent, as well as Indian firms such as Sun Pharma and Dr. Reddy’s, differentiating through cost‑effective pricing and a broad international regulatory footprint.